Insider · CIK 0001709024

Martin Samuel Bates

Reports to the SEC for 1 company · HAMPTON, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001709024

Forms 4 and 5

Insider transactions

49 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-25	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (right to buy)A Award	SVP AND CFO	AAward	+93K sh	—	—	93,000
2026-01-02	CLDXCelldex Therapeutics, Inc.M Exercise/Conversion	SVP AND CFO	MExercise/Conversion	+4,817 sh	$10.38	+$50K	32,942
2026-01-02	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (Right to Buy)M Exercise/Conversion	SVP AND CFO	MExercise/Conversion	−4,817 sh	—	—	58,815
2025-06-05	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (right to buy)A Award	SVP AND CFO	AAward	+81K sh	—	—	81,000
2024-06-14	CLDXCelldex Therapeutics, Inc.M Exercise/Conversion	SVP AND CFO	MExercise/Conversion	+3,201 sh	$9.02	+$28.9K	28,329
2024-06-14	CLDXCelldex Therapeutics, Inc.M Exercise/Conversion	SVP AND CFO	MExercise/Conversion	+17K sh	$10.38	+$176K	45,297
2024-06-14	CLDXCelldex Therapeutics, Inc.S Sale	SVP AND CFO	SSale	−17.2K sh	$35.42	−$608K	28,125
2024-06-14	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (Right to Buy)M Exercise/Conversion	SVP AND CFO	MExercise/Conversion	−3,201 sh	—	—	0
2024-06-14	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (Right to Buy)M Exercise/Conversion	SVP AND CFO	MExercise/Conversion	−17K sh	—	—	63,632
2024-06-13	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (right to buy)A Award	SVP AND CFO	AAward	+81K sh	—	—	81,000
2024-05-30	CLDXCelldex Therapeutics, Inc.M Exercise/Conversion	SVP AND CFO	MExercise/Conversion	+25K sh	$10.38	+$260K	60,128
2024-05-30	CLDXCelldex Therapeutics, Inc.S Sale	SVP AND CFO	SSale	−35K sh	$34.05	−$1.19M	25,128
2024-05-30	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (Right to Buy)M Exercise/Conversion	SVP AND CFO	MExercise/Conversion	−25K sh	—	—	80,600
2024-01-02	CLDXCelldex Therapeutics, Inc.M Exercise/Conversion	SVP AND CFO	MExercise/Conversion	+10.8K sh	$2.78	+$29.9K	35,128
2024-01-02	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (Right to Buy)M Exercise/Conversion	SVP AND CFO	MExercise/Conversion	−10.8K sh	—	—	0
2023-06-15	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (right to buy)A Award	SVP AND CFO	AAward	+80K sh	—	—	80,000
2022-08-12	CLDXCelldex Therapeutics, Inc.M Exercise/Conversion	SVP AND CFO	MExercise/Conversion	+3,876 sh	$9.02	+$34.9K	28,254
2022-08-12	CLDXCelldex Therapeutics, Inc.M Exercise/Conversion	SVP AND CFO	MExercise/Conversion	+13.7K sh	$2.78	+$38K	41,925
2022-08-12	CLDXCelldex Therapeutics, Inc.S Sale	SVP AND CFO	SSale	−14.3K sh	$36.76	−$524K	27,664
2022-08-12	CLDXCelldex Therapeutics, Inc.S Sale	SVP AND CFO	SSale	−2,065 sh	$35.38	−$73.1K	25,599
2022-08-12	CLDXCelldex Therapeutics, Inc.S Sale	SVP AND CFO	SSale	−1,221 sh	$34.62	−$42.3K	24,378
2022-08-12	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (Right to Buy)M Exercise/Conversion	SVP AND CFO	MExercise/Conversion	−3,876 sh	—	—	3,201
2022-08-12	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (Right to Buy)M Exercise/Conversion	SVP AND CFO	MExercise/Conversion	−13.7K sh	—	—	10,750
2022-08-11	CLDXCelldex Therapeutics, Inc.M Exercise/Conversion	SVP AND CFO	MExercise/Conversion	+2,453 sh	$9.02	+$22.1K	26,831
2022-08-11	CLDXCelldex Therapeutics, Inc.S Sale	SVP AND CFO	SSale	−2,453 sh	$37.04	−$90.9K	24,378
2022-08-11	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (Right to Buy)M Exercise/Conversion	SVP AND CFO	MExercise/Conversion	−2,453 sh	—	—	7,077
2022-06-16	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (right to buy)A Award	SVP AND CFO	AAward	+85K sh	—	—	85,000
2021-12-23	CLDXCelldex Therapeutics, Inc.M Exercise/Conversion	SVP AND CFO	MExercise/Conversion	+3,250 sh	$9.02	+$29.3K	30,128
2021-12-23	CLDXCelldex Therapeutics, Inc.M Exercise/Conversion	SVP AND CFO	MExercise/Conversion	+3,750 sh	$2.78	+$10.4K	33,878
2021-12-23	CLDXCelldex Therapeutics, Inc.S Sale	SVP AND CFO	SSale	−9,500 sh	$42.00	−$399K	24,378
2021-12-23	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (Right to Buy)M Exercise/Conversion	SVP AND CFO	MExercise/Conversion	−3,250 sh	—	—	9,530
2021-12-23	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (Right to Buy)M Exercise/Conversion	SVP AND CFO	MExercise/Conversion	−3,750 sh	—	—	24,421
2021-11-15	CLDXCelldex Therapeutics, Inc.M Exercise/Conversion	SVP AND CFO	MExercise/Conversion	+3,250 sh	$9.02	+$29.3K	32,628
2021-11-15	CLDXCelldex Therapeutics, Inc.M Exercise/Conversion	SVP AND CFO	MExercise/Conversion	+3,750 sh	$2.78	+$10.4K	36,378
2021-11-15	CLDXCelldex Therapeutics, Inc.S Sale	SVP AND CFO	SSale	−7,452 sh	$43.92	−$327K	28,926
2021-11-15	CLDXCelldex Therapeutics, Inc.S Sale	SVP AND CFO	SSale	−2,048 sh	$42.27	−$86.6K	26,878
2021-11-15	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (Right to Buy)M Exercise/Conversion	SVP AND CFO	MExercise/Conversion	−3,250 sh	—	—	12,780
2021-11-15	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (Right to Buy)M Exercise/Conversion	SVP AND CFO	MExercise/Conversion	−3,750 sh	—	—	28,171
2021-08-10	CLDXCelldex Therapeutics, Inc.M Exercise/Conversion	SVP AND CFO	MExercise/Conversion	+10.3K sh	$9.02	+$92.9K	21,037
2021-08-10	CLDXCelldex Therapeutics, Inc.S Sale	SVP AND CFO	SSale	−2,056 sh	$45.25	−$93K	18,981
2021-08-10	CLDXCelldex Therapeutics, Inc.M Exercise/Conversion	SVP AND CFO	MExercise/Conversion	+11.1K sh	$2.78	+$30.8K	30,060
2021-08-10	CLDXCelldex Therapeutics, Inc.S Sale	SVP AND CFO	SSale	−682 sh	$45.25	−$30.9K	29,378
2021-08-10	CLDXCelldex Therapeutics, Inc. · Incentive Stock OptionM Exercise/Conversion	SVP AND CFO	MExercise/Conversion	−10.3K sh	—	—	16,030
2021-08-10	CLDXCelldex Therapeutics, Inc. · Incentive Stock OptionM Exercise/Conversion	SVP AND CFO	MExercise/Conversion	−11.1K sh	—	—	31,921
2021-06-17	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (right to buy)A Award	SVP AND CFO	AAward	+85K sh	—	—	85,000
2020-06-18	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (right to buy)A Award	SVP AND CFO	AAward	+106K sh	—	—	105,600
2020-06-09	CLDXCelldex Therapeutics, Inc.P Purchase	SVP AND CFO	PPurchase	+9,750 sh	$3.05	+$29.7K	10,735
2019-06-19	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (right to buy)A Award	SVP AND CFO	AAward	+43K sh	—	—	43,000
2018-06-13	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (right to buy)A Award	SVP AND CFO	AAward	+395K sh	—	—	395,000

Recent filings

Accepted (ET)
Jun 294
Martin Samuel Bates0001709024-26-000004
SEC(opens sec.gov)
Jan 64
Martin Samuel Bates0001709024-26-000002
SEC(opens sec.gov)
Jun 94
Martin Samuel Bates0001415889-25-016242
SEC(opens sec.gov)
Jun 184
Martin Samuel Bates0001415889-24-017363
SEC(opens sec.gov)
Jun 174
Martin Samuel Bates0001415889-24-017163
SEC(opens sec.gov)
Jun 34
Martin Samuel Bates0001415889-24-015147
SEC(opens sec.gov)
Jan 44
Martin Samuel Bates0001415889-24-000592
SEC(opens sec.gov)
Jun 204
Martin Samuel Bates0001415889-23-010046
SEC(opens sec.gov)
Aug 154
Martin Samuel Bates0001415889-22-008608
SEC(opens sec.gov)

Companies

Celldex Therapeutics, Inc.SVP AND CFOCLDX

Address

C/O CELLDEX THERAPEUTICS, INC. 53 FRONTAGE ROAD, SUITE 220

HAMPTON, NJ, 08827